Alzheimer’s Disease

Alzheimer’s is a devastating disease for both patients and families. More than 5 million Americans have Alzheimer’s disease or related disorders that lead to a loss of mental function. Discover how NewYork-Presbyterian’s collaborative approach to treating this disease provides compassionate and sensitive care from a multidisciplinary team, which includes neurologists, neurosurgeons, psychiatrists, neuropsychologists, nurses, social workers, and genetic counselors. Learn how genetic testing, clinical trials, and prevention approaches also set NewYork-Presbyterian apart. Here, you’ll find strategies for spotting Alzheimer’s in seniors, and discover the story behind NewYork-Presbyterian/Columbia University Irving Medical Center research teams who are looking into early detection methods. Learn about the work of Dr. Scott A. Small, director of the Alzheimer’s Disease Research Center at Columbia University Irving Medical Center and the Boris and Rose Katz Professor of Neurology at Columbia University Vagelos College of Physicians and Surgeons. Through the use of cutting-edge neuroimaging technology, Dr. Small is working to identify the causes of Alzheimer’s and determine precisely how the disease affects the brain. You’ll also explore the story of how Dr. Richard Isaacson, who specializes in Alzheimer’s prevention at NewYork-Presbyterian/Weill Cornell Medical Center and is the founder of the Alzheimer’s Prevention Clinic and the Weill Cornell Memory Disorders Program, became a leading figure in the field of Alzheimer’s treatment.